Infections and Infectious Diseases

Phase I Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

Condition:   Polio
Interventions:   Biological: dmLT;   Biological: fIPV
Sponsor:   University of Vermont
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffAdjuvant | Coli | dmLT | Double | Enterotoxigenic | Escherichia | Evaluation | fIPV | Fractionaldose | Given | Heat | Immunogenicity | Inactivated | Intradermally | Labile | Mutant | Phase | Polio | Reactogenicity | Safety | Toxin | Vaccine
Read more 
Free Clinical Trial Updates

    #1 Best New Product in 2019
    Headache Relief Shampoo Banner Ad
    Search For Clinical Trials
      CLOSE
      Please click to geolocate button to change this value.
      SEARCHRESET
      Featured Research Centers